FDA Faces Backlash Over Approval of Test for OUD Risk

April 12, 2024

The FDA is under scrutiny for approving a genetic test designed to assess a person’s risk for
opioid use disorder (OUD). The test, which is intended for identifying individuals at higher
addiction risk before prescribing opioids, claims to predict susceptibility using 15 genetic
markers. Critics argue it could worsen the OUD and drug poisoning crisis, citing concerns over
accuracy and the potential for misdiagnoses.

Learn more about the genetic test here.